Therapy of Metastatic Melanoma with BRAF Inhibitors

被引：0
|
作者：
Hafner, C. [1 ]
机构：
[1] Univ Regensburg, Klin & Poliklin Dermatol, D-93053 Regensburg, Germany
来源：
HAUTARZT | 2011年 / 62卷 / 09期
关键词：
RAF; RESISTANCE; MUTATIONS; PATHWAY; NEVI;
D O I：
10.1007/s00105-011-2232-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：696 / 698
页数：3
相关论文
共 50 条
  • [1] Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma
    Cann, Christopher G.
    Tillman, Benjamin F.
    Davis, Elizabeth J.
    Johnson, Douglas B.
    ONCOLOGIST, 2019, 24 (11) : 1495 - 1496
  • [2] BRAF Inhibitors and Melanoma
    Flaherty, Keith T.
    CANCER JOURNAL, 2011, 17 (06) : 505 - 511
  • [3] Overcoming Metastatic Melanoma with BRAF Inhibitors
    Hong, Seunghee
    Hong, Sungwoo
    Han, Sang-Rae
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (05) : 699 - 701
  • [4] Resistant mechanisms to BRAF inhibitors in melanoma
    Manzano, Jose Luis
    Layos, Laura
    Buges, Cristina
    de los Llanos Gil, Maria
    Vila, Laia
    Martinez-Balibrea, Eva
    Martinez-Cardus, Anna
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (12) : 1 - 9
  • [5] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    Smalley, K. S. M.
    Flaherty, K. T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 431 - 435
  • [6] The Nature and Management of Metastatic Melanoma After Progression on BRAF Inhibitors: Effects of Extended BRAF Inhibition
    Chan, Matthew M. K.
    Haydu, Lauren E.
    Menzies, Alexander M.
    Azer, Mary W. F.
    Klein, Oliver
    Lyle, Megan
    Clements, Arthur
    Guminski, Alexander
    Kefford, Richard F.
    Long, Georgina V.
    CANCER, 2014, 120 (20) : 3142 - 3153
  • [7] Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma
    Kim, Hee Kyung
    Lee, Sunyoung
    Kim, Kyung
    Heo, Mi Hwa
    Lee, Hansang
    Cho, Jinhyun
    Kim, Nayoung K. D.
    Park, Woongyang
    Lee, Su Jin
    Kim, Jung Han
    Jang, Kee-Taek
    Choi, Sang-Hee
    Lee, Jeeyun
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 557 - 564
  • [8] Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
    Luke, Jason J.
    Hodi, F. Stephen
    CLINICAL CANCER RESEARCH, 2012, 18 (01) : 9 - 14
  • [9] BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance
    Alcala, Alexander Marzuka
    Flaherty, Keith T.
    CLINICAL CANCER RESEARCH, 2012, 18 (01) : 33 - 39
  • [10] BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma
    Cybulska-Stopa, Bozena
    Rogala, Pawel
    Czarnecka, Anna M.
    Galus, Lukasz
    Dziura, Robert
    Rajczykowski, Marcin
    Kubiatowski, Tomasz
    Wisniewska, Magdalena
    Gega-Czarnota, Adrianna
    Teterycz, Pawel
    Ziobro, Marek
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    MELANOMA RESEARCH, 2020, 30 (05) : 465 - 471
12345